Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Nanovibronix Inc (NAOV)
Nanovibronix Inc (NAOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nanovibronix Inc 525 EXECUTIVE BLVD ELMSFORD NY 10523 USA

P: 914-233-3004 F: 914-376-6111

Description:

NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.

Key Statistics

Overview:

Market Capitalization, $K 4,816
Enterprise Value, $K -2,924
Shares Outstanding, K 1,400
Annual Sales, $ 1,700 K
Annual Net Income, $ -14,280 K
Last Quarter Sales, $ 100 K
Last Quarter Net Income, $ -960 K
60-Month Beta 0.93
% of Insider Shareholders 6.73%
% of Institutional Shareholders 5.27%
Float, K 1,306
% Float 93.27%
Short Volume Ratio 0.11

Growth:

1-Year Return -79.38%
3-Year Return -92.59%
5-Year Return -96.29%
5-Year Revenue Growth 639.13%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.60 on 11/14/22
Next Earnings Date 04/03/23
Earnings Per Share ttm -2.40
EPS Growth vs. Prev Qtr 40.00%
EPS Growth vs. Prev Year 66.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 02/09/23

NAOV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -124.33%
Return-on-Assets % -83.65%
Profit Margin % -840.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 2.89
Price/Cash Flow N/A
Price/Book 1.56
Book Value/Share 2.25
Interest Coverage -284.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar